Lower risk Drug recall · FDA · Published April 12, 2021

Preferred Pharmaceuticals recalls Cephalexin oral suspension due to impurities

Preferred Pharmaceuticals recalls Cephalexin oral suspension (250mg/5mL) for potential impurities found during testing. This is a repackaged product from Ascend Laboratories. No immediate action needed as it's prescription-only.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0342-2021Drug Preferred Pharmaceuticals ›

Lower-risk recall

Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin

Take action

Contact the company

Recalling firmPreferred Pharmaceuticals, Inc.1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801

✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals is recalling a specific Cephalexin oral suspension product due to impurities detected during testing. This is a prescription-only medication that was repackaged by Preferred Pharmaceuticals from Ascend Laboratories. The recall does not require immediate action as the product is not intended for general use. Read more at govinfonow.com/recall/36213-preferred-pharmaceuticals-recalls-cephalexin-oral-suspension-due-to-impurities.

Source Summary by GovInfoNow · govinfonow.com/recall/36213-preferred-pharmaceuticals-recalls-cephalexin-oral-suspension-due-to-impurities · Updated October 4, 2026 · FDA enforcement record: FDA #D-0342-2021

Cite this page

“Preferred Pharmaceuticals recalls Cephalexin oral suspension due to impurities.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36213-preferred-pharmaceuticals-recalls-cephalexin-oral-suspension-due-to-impurities. Based on FDA recall #D-0342-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0342-2021%22&limit=1).

The FDA announced on April 12, 2021, that Preferred Pharmaceuticals, Inc. voluntarily recalled Cephalexin for Oral Suspension due to failed impurity specifications. The recall affects six bottles distributed to three physicians in California.

How to tell if you have it

Brand: Preferred Pharmaceuticals
Product: Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only
NDC #: 68788-7529-1
Lot #: B1121W
Exp.Date: 04/2022
Quantity: Six bottles
Distribution: Three physicians in CA

The hazard

The product contains out-of-specification individual unidentified impurities detected during related substance test analysis. The recall is classified as Class II.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has had 32 other recalls since August 15, 2018. Recent brand recalls include a September 28, 2026 lidocaine ointment recall for content issues and a March 25, 2026 Geri-Care eye drops recall for sterility risk. Other recent recalls of similar products include a June 7, 2026 OneSource Specialty Pharma methohexital sodium recall for impurities risk and a December 30, 2025 Sun Pharmaceutical fluocinolone acetonide solution recall for impurity risk.

How to tell if you have this one

Check for the product name 'Cephalexin for Oral Suspension, Generic for Keflex, USP', 250 mg/5mL concentration, and package size of 100. The product was repackaged by Preferred Pharmaceuticals, Inc. with NDC number 68788-7529-1 and lot number B1121W, expiring April 2022.

Brand
Preferred Pharmaceuticals
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Verify the product name, concentration, and package size to confirm if it matches the recalled item.

Where it went and when

Where it was distributed

Distributed in California.

FDA distribution: “recalled product was distributed to three physicians located CA” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California.

Recall timeline

FDA published this recall 23 days after the firm started it.

Apr 12, 2021Firm started the recall
Apr 26, 2021FDA classified it Class II
May 5, 2021Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Preferred Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/36213-preferred-pharmaceuticals-recalls-cephalexin-oral-suspension-due-to-impurities">Preferred Pharmaceuticals recalls Cephalexin oral suspension due to impurities (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0342-2021 (April 12, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0342-2021 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.